Protected: SuVit Investments Takes Strategic Position in CheckRare to Accelerate Growth, Build Out Platform, and Expand Healthcare Professional Analytics
Password Protected
To view this protected post, enter the password below:
2025 Orphan Drugs: PDUFA Dates and FDA Approvals
Below is the list of important regulatory dates for all orphan drugs for 2025. Prescription Drug User Fee Act (PDUFA) dates refer to deadlines for the FDA to review new drugs. PDUFA DateOrphan DrugIndicationCompanyStatus 1.7.2025. Ryoncil...Protected: BRIGHT Phase III Trial: Evaluating Pegunigalsidase Alfa
Password Protected
To view this protected post, enter the password below:
Rare Disease Market in Denmark: Key Players and Market Dynamics
In July of 2024, I visited Denmark and Italy to research their health systems as it pertains to rare diseases. In Denmark, I visited Copenhagen University and met with Oncology professionals to understand their views on rare diseases and rare blood disorders. I also...